Skip to content

Daily vs Alternate Day Iron Doses in Children with Iron Deficiency Anemia: Which Works Better?

Comparison of Conventional Daily Iron Therapy vs Alternate Day Iron Therapy in Children with Iron Deficiency Anemia: A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091237
Enrollment
60
Registered
2025-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

Intervention1: Supplementation of Iron in alternate days in Iron deficiency anemia Children: Supplementing Iron in Ferrous Ascorbate formulation Syrup in alternate days to Iron Deficiency Anemia Child

Sponsors

Ohm Ashwin M
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children aged 3 years to 12 years patients with Iron Deficiency Anemia defined by Hb less than 10 mg/dL Peripheral smear showing microcytic hypochromic blood picture And or Serum Ferritin less than12 micro gm/L in children less than 5 years and less than 15 micro gm/L in children more than 5 years.

Exclusion criteria

Exclusion criteria: Allergy to oral iron - Known history of inflammatory bowel disease, celiac disease, thalassemia or thalassemia trait - Known case of any bleeding disorder - Known intolerance or lack of response to oral ferrous iron forms - Intravenous iron therapy in the past 12 weeks - Children with Chronic Kidney Disease, Chronic Liver Disease, Cardiac Failure, Concomitant Malignancy, Hemolytic Anemias ( including hemoglobinopathies ) - Surgery, chemotherapy or blood donation planned in upcoming 12 weeks

Design outcomes

Primary

MeasureTime frame
To determine the efficacy & safety of alternate day oral iron therapy with daily oral iron therapy in children with Iron deficiency AnemiaTimepoint: At Baseline, at the end of 4th week, 8th week and 12th week

Secondary

MeasureTime frame
Comparing the increase in Hemoglobin, Mean Corpuscular Volume, Mean Corpuscular Haemoglobin in both groupsTimepoint: At Baseline, at the end of 4th week, 8th week aand 12th week

Countries

India

Contacts

Public ContactOhm Ashwin M

Thanjavur Medical College

drselva_kumar69@yahoo.co.in9842452437

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026